CymaBay Therapeutics Cash from Investing (TTM) Trends

CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)

32.48 0.00 (0.00%) USD | NASDAQ | Mar 25, 16:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-86.57M
September 30, 2023	-36.11M
June 30, 2023	-56.12M
March 31, 2023	-55.64M
December 31, 2022	-45.98M
September 30, 2022	-78.42M
June 30, 2022	-45.58M
March 31, 2022	-38.10M
December 31, 2021	48.59M
September 30, 2021	68.32M
June 30, 2021	-1.302M
March 31, 2021	37.02M
December 31, 2020	47.96M
September 30, 2020	61.57M
June 30, 2020	141.40M
March 31, 2020	21.33M
December 31, 2019	-34.35M
September 30, 2019	-16.84M
June 30, 2019	-43.74M
March 31, 2019	26.50M
December 31, 2018	-54.11M

Date	Value
September 30, 2018	-75.78M
June 30, 2018	-159.30M
March 31, 2018	-153.96M
December 31, 2017	-67.53M
September 30, 2017	-62.81M
June 30, 2017	9.491M
March 31, 2017	4.273M
December 31, 2016	27.13M
September 30, 2016	23.52M
June 30, 2016	-1.821M
March 31, 2016	7.449M
December 31, 2015	-11.08M
September 30, 2015	-14.40M
June 30, 2015	-0.231M
March 31, 2015	-16.39M
December 31, 2014	-16.94M
September 30, 2014	-26.52M
June 30, 2014	-15.44M
March 31, 2014	-5.681M
December 31, 2013	-6.231M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-86.57M

Minimum

Dec 2023

141.40M

Maximum

Jun 2020

-5.924M

Average

-34.35M

Median

Dec 2019

Cash from Investing (TTM) Benchmarks